140 related articles for article (PubMed ID: 37935302)
21. Knockdown of lysine (K)-specific demethylase 2B KDM2B inhibits glycolysis and induces autophagy in lung squamous cell carcinoma cells by regulating the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.
Xie Z; Li H; Zang J
Bioengineered; 2021 Dec; 12(2):12227-12235. PubMed ID: 34783291
[TBL] [Abstract][Full Text] [Related]
22. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
[TBL] [Abstract][Full Text] [Related]
23. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors.
Sasaki Y; Higashijima Y; Suehiro JI; Sugasawa T; Oguri-Nakamura E; Fukuhara S; Nagai N; Hirakawa Y; Wada Y; Nangaku M; Kanki Y
Biochem Biophys Res Commun; 2022 May; 605():16-23. PubMed ID: 35306360
[TBL] [Abstract][Full Text] [Related]
24. METTL3 orchestrates glycolysis by stabilizing the c-Myc/WDR5 complex in triple-negative breast cancer.
Yuan XN; Shao YC; Guan XQ; Liu Q; Chu MF; Yang ZL; Li H; Zhao S; Tian YH; Zhang JW; Wei L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119716. PubMed ID: 38547933
[TBL] [Abstract][Full Text] [Related]
25. The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility.
Zacharopoulou N; Kallergi G; Alkahtani S; Tsapara A; Alarifi S; Schmid E; Sukkar B; Kampranis S; Lang F; Stournaras C
Cancer Biol Ther; 2020 Jun; 21(6):533-540. PubMed ID: 32175798
[TBL] [Abstract][Full Text] [Related]
26. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
Han XR; Zha Z; Yuan HX; Feng X; Xia YK; Lei QY; Guan KL; Xiong Y
Oncogene; 2016 Aug; 35(32):4179-90. PubMed ID: 26725323
[TBL] [Abstract][Full Text] [Related]
27. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
28. ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis.
Gao Y; Feng L; Zhang L; Geng J; Zhang E
Dis Markers; 2022; 2022():7527996. PubMed ID: 36051358
[TBL] [Abstract][Full Text] [Related]
29. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
[TBL] [Abstract][Full Text] [Related]
30. KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism.
Zhao E; Ding J; Xia Y; Liu M; Ye B; Choi JH; Yan C; Dong Z; Huang S; Zha Y; Yang L; Cui H; Ding HF
Cell Rep; 2016 Jan; 14(3):506-519. PubMed ID: 26774480
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
[TBL] [Abstract][Full Text] [Related]
32. The KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapy.
Karoopongse E; Yeung C; Byon J; Ramakrishnan A; Holman ZJ; Jiang PY; Yu Q; Deeg HJ; Marcondes AM
PLoS One; 2014; 9(9):e107817. PubMed ID: 25225797
[TBL] [Abstract][Full Text] [Related]
33. Histone H2A deubiquitinases in the transcriptional programs of development and hematopoiesis: a consolidated analysis.
Wang H; Langlais D; Nijnik A
Int J Biochem Cell Biol; 2023 Apr; 157():106384. PubMed ID: 36738766
[TBL] [Abstract][Full Text] [Related]
34. ATF4-dependent regulation of the JMJD3 gene during amino acid deprivation can be rescued in Atf4-deficient cells by inhibition of deacetylation.
Shan J; Fu L; Balasubramanian MN; Anthony T; Kilberg MS
J Biol Chem; 2012 Oct; 287(43):36393-403. PubMed ID: 22955275
[TBL] [Abstract][Full Text] [Related]
35. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
[TBL] [Abstract][Full Text] [Related]
36. Kdm2b Regulates Somatic Reprogramming through Variant PRC1 Complex-Dependent Function.
Zhou Z; Yang X; He J; Liu J; Wu F; Yu S; Liu Y; Lin R; Liu H; Cui Y; Zhou C; Wang X; Wu J; Cao S; Guo L; Lin L; Wang T; Peng X; Qiang B; Hutchins AP; Pei D; Chen J
Cell Rep; 2017 Nov; 21(8):2160-2170. PubMed ID: 29166607
[TBL] [Abstract][Full Text] [Related]
37. SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation.
Kwon DH; Kang JY; Joung H; Kim JY; Jeong A; Min HK; Shin S; Lee YG; Kim YK; Seo SB; Kook H
Exp Mol Med; 2021 Feb; 53(2):250-263. PubMed ID: 33564100
[TBL] [Abstract][Full Text] [Related]
38. Histone H3K79 demethylation by KDM2B facilitates proper DNA replication through PCNA dissociation from chromatin.
Kang JY; Park JW; Hahm JY; Jung H; Seo SB
Cell Prolif; 2020 Nov; 53(11):e12920. PubMed ID: 33029857
[TBL] [Abstract][Full Text] [Related]
39. Polycomb complex recruitment in pluripotent stem cells.
Barrero MJ; Izpisua Belmonte JC
Nat Cell Biol; 2013 Apr; 15(4):348-50. PubMed ID: 23548929
[TBL] [Abstract][Full Text] [Related]
40. KDM2B regulates choline kinase expression and neuronal differentiation of neuroblastoma cells.
Domizi P; Malizia F; Chazarreta-Cifre L; Diacovich L; Banchio C
PLoS One; 2019; 14(1):e0210207. PubMed ID: 30629659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
